Cargando…

Drivers of federal spending in pharmaceuticals of the Specialized Component: measurement and analysis

OBJECTIVES: Quantify and analyze the contribution of the main drivers of federal spending in pharmaceuticals purchase from the Specialized Component of Pharmaceutical Care (CEAF) in the period from 2010 to 2019. METHODS: An analysis of the annual expenditure's decomposition of the Brazilian Min...

Descripción completa

Detalles Bibliográficos
Autor principal:	Vieira, Fabiola Sulpino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Saúde Pública da Universidade de São Paulo 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647991/ https://www.ncbi.nlm.nih.gov/pubmed/34910025 http://dx.doi.org/10.11606/s1518-8787.2021055003097

Ejemplares similares

Integrality of the therapeutic and pharmaceutical care: a necessary debate
por: Vieira, Fabiola Sulpino
Publicado: (2017)

Distortions of parliamentary amendments to the equitable allocation of federal resources to the PAB
por: Vieira, Fabiola Sulpino, et al.
Publicado: (2022)

Health financing in Brazil and the goals of the 2030 Agenda: high risk of failure
por: Vieira, Fabiola Sulpino
Publicado: (2020)

A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021)

Impacts of a Brazilian pharmaceutical program on the health of chronic patients
por: de Almeida, Aléssio Tony Cavalcanti, et al.
Publicado: (2019)

Regular access and adherence to medications of the specialized component of pharmaceutical services
por: Fritzen, Janaína Soder, et al.
Publicado: (2017)

Fiscal policies in the Federation of Bosnia and Herzegovina: are spending or revenue measures more effective?
por: Weyerstrass, Klaus, et al.
Publicado: (2023)

Judicialization and right to health in Brazil: a trajectory of matches and mismatches
por: Vieira, Fabiola Sulpino
Publicado: (2023)

The federal spending power: Building forward after the pandemic
por: Miller, Fiona A.
Publicado: (2021)

A historical dataset of federal government spending changes for Canada
por: Hussain, Syed Muhammad, et al.
Publicado: (2022)

Medicaid, the uninsured, and national health spending: Federal policy implications
por: Garrison, Louis P.
Publicado: (1990)

Impact of Covid-19 containment on community pharmaceutical spending in Andalusia - Spain
por: Florido Alba, Francisco, et al.
Publicado: (2021)

Pharmaceutical Spending and German Reunification: Parity Comes Quickly to Berlin
por: Katz, Eric M.
Publicado: (1994)

The New and Old Europe: East-West Split in Pharmaceutical Spending
por: Jakovljevic, Mihajlo, et al.
Publicado: (2016)

Decomposition of the drivers of the U.S. hospital spending growth, 2001–2009
por: Wu, Vivian Y, et al.
Publicado: (2014)

International Pharmaceutical Spending Controls: France, Germany, Sweden, and the United Kingdom
por: Gross, David J., et al.
Publicado: (1994)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)

Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
por: Hernandez, Inmaculada, et al.
Publicado: (2017)

Was federal parity associated with changes in Out-of-network mental health care use and spending?
por: Busch, Susan H., et al.
Publicado: (2017)

Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
por: Kamyari, Naser, et al.
Publicado: (2021)

Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
por: Lexchin, Joel
Publicado: (2018)

Drivers of medical spending behaviour amid the COVID-19 pandemic: Heuristic or systematic
por: Phan, Truc Nha Thi, et al.
Publicado: (2022)

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
por: Parker, Lisa, et al.
Publicado: (2019)

Unraveling the drivers of regional variation in healthcare spending by analyzing prevalent chronic diseases
por: de Vries, Eline F., et al.
Publicado: (2018)

Trends and drivers of government health spending in sub-Saharan Africa, 1995–2015
por: Micah, Angela E, et al.
Publicado: (2019)

Public policy coverage and access to medicines in Brazil
por: de Moraes, Ricardo Montes, et al.
Publicado: (2022)

Pharmaceutical Specialities, &c.
Publicado: (1926)

Output and inflation components of medical care and other spending changes
por: Peden, Edgar A., et al.
Publicado: (1991)

Epistemology of public spending as a component of interventionist fiscal policy
por: Robles Cuevas, Hugo Oliver, et al.
Publicado: (2023)

The Impact of Global Budgets on Pharmaceutical Spending and Utilization: Early Experience From the Alternative Quality Contract
por: Afendulis, Christopher C., et al.
Publicado: (2014)

Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019
por: Galkina Cleary, Ekaterina, et al.
Publicado: (2023)

Diagnoses, prevalence, and state-based federal spending for HIV prevention and treatment in the United States, 2006–2009
por: Oglesby, Willie H, et al.
Publicado: (2014)

The Intersection of Antimicrobial Stewardship, the Pharmaceutical Industry, and the Federal Legislature
por: Gregory, Eric, et al.
Publicado: (2022)

Federated horizontally partitioned principal component analysis for biomedical applications
por: Hartebrodt, Anne, et al.
Publicado: (2022)

Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus
por: Guzmán-Mejía, Fabiola, et al.
Publicado: (2023)

The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)
por: Shah, Vinod P., et al.
Publicado: (2010)

Spending the Summer
Publicado: (1871)

Special issue: Pharmaceutical innovation
por: Sriamornsak, Pornsak, et al.
Publicado: (2018)

Medical Spending of the US Elderly
por: De Nardi, Mariacristina, et al.
Publicado: (2016)

DESPERATE TIMES CALL FOR DESPERATE MEASURES: GOVERNMENT SPENDING MULTIPLIERS IN HARD TIMES
por: Lee, Sokbae, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvk38ibe3lng5ifpffiv2s9ts9